• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Rize raises $11.4M to scale its embedded fintech service

September 28, 2021 by David Barret Leave a Comment

Rize, a fintech-as-a-service company that provides services to other firms, announced an $11.4 million Series A this morning. The funding event was led by Alpha Edison and Morpheus Ventures. A number of the startup’s prior backers also participated in the round.

Rize is an interesting company in a competitive space; the market for building financial technology products for use by customers enjoys a great number of players. Rize hopes to compete by allowing its customers to leverage a single API for more than one account type, unifying its offering to a single developer hook.

More importantly, Rize has built something that it calls “synthetic accounts.” For those of us who last heard the word “synthetic” in a financial context attached to the phrase “CDO,” this may sound concerning. It’s not. Instead, synthetic accounts allow Rize to provide customers of its banking services a way to create a unified account for end users not tied to a single custodial account type. In practice, synthetic accounts allow Rize to offer end users (the customers of its customers) the ability to combine different custodial accounts (checking, brokerage) into a single experience.

Per a white paper from Rize, by offering a single “synthetic account core,” its customers can create a more cohesive and programmable financial experience for end users. And the synthetic account system will allow Rize customers to add more services to their financial technology offerings as Rize itself expands its feature set.

Morpheus Ventures’ Howard Ko brought up the company’s synthetic account work in a statement to TechCrunch, saying that it was that feature of its service that “attracted” his firm to the startup, as it “essentially abstracts all the plumbing required to develop a broad spectrum of fintech products and services that developers are looking to build into a simplified singular API connection.”

In an interview with senior leadership, Rize told TechCrunch that it has built a compliance management system into its product, likening compliance work to logistics in the e-commerce world — something critical that is both complicated and not a task that folks relish taking on. Rize wants to alleviate a chunk of that burden, potentially smoothing the path for businesses to select its offering over those of rival banking-as-a-service players.

Rize has completed the core banking pieces of its product — the startup we see today is the result of a B2B pivot from B2C roots — with brokerage support coming next. New capital should help the company expand its product mix.

Notably, Rize’s leadership told TechCrunch that it wound up raising its Series A earlier than it anticipated. The startup had expected slower market traction, it said, but greater-than-anticipated demand meant that Rize had larger human capital needs. So, external funds were the obvious choice.

Rize executed its B2B pivot with a team of around 15, expanding to just over 30 today. The company expects to have nearly 50 staff by the end of the year.

Eventually, there will be consolidation in the banking-as-a-service, or BaaS, space. But we likely won’t see that wave crest until there’s less white space for startups to eat into. And by the time that that occurs, startups like Rize will hope to be on the acquiring side of the equation. Let’s see how quickly Rize can scale both customer and revenue volume with this Series A.

Source Link Rize raises $11.4M to scale its embedded fintech service

David Barret
David Barret

Related posts:

  1. Malaysia holiday hotspot readies for reopening with tourism bubble
  2. Popular Netflix series sparks new debate over S.Korea’s military conscription
  3. Tennis-Greek Sakkari boosts chances of making WTA Finals cut
  4. Georgian ex-president says he will fly home, despite jail threat, to ‘save the country’

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Geophagia – Why Some People Eat Soil, And Whether You Should Try It Too (Spoiler: No)
  • Rare Moonlit Night On Mars Captured By Perseverance
  • This Strange, Supergiant Amphipod Inhabits Up To 59 Percent Of The World’s Seabed
  • The Pineal Gland Is Mysterious, But It’s Probably Not A Psychic “Third Eye”
  • New Contact Lenses Give You Infrared Vision Even With Your Eyes Shut
  • Only 2 Species Of This “Living Fossil” Exist – And 1 Was Just Photographed In The Wild For The First Time
  • New Sun Images At 8K Resolution Show Astounding, Never-Before-Seen Details
  • Why Do Ostriches Have Four Kneecaps If They Only Have Two Legs?
  • Toad In The Hole: The Myth And Mystery Of The Living Frogs Entombed In Rocks
  • Newest Member Of The Solar System Just Announced – And It’s In An Extreme Orbit
  • Meet Walckenaer’s Studded Triangular Spider And The Rest Of Its Triangular Family
  • World’s Largest Cliff-Top Boulder Was Rolled From 30-Meter-High Cliff By Ancient Tsunami
  • Flowers Have Been Blooming On Earth For 2 Million Years Longer Than We Thought
  • New Species Of Flapjack Octopus, A Shape-Shifting Cephalopod Of The Deep, Found In Australia
  • Galaxy Blasts Its Companion With Radiation In Never-Before-Seen “Cosmic Joust”
  • Electroacupuncture Is Acupuncture’s Livelier Cousin – But Does It Work?
  • Myth, Mess, and Mitochondria: How The Biggest Bird To Ever Exist Evolved And Died In Madagascar
  • Why Do Leftovers Taste Better The Next Day?
  • “There’s The Potential For Life To Exist”: Where Is Life Most Likely To Be In The Solar System?
  • Are Cold Sores Really Linked To Alzheimer’s Disease? Here’s What The Experts Are Saying
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version